C 27 H 27 N 3 O 2 , triclinic, P1 (no. 2), a = 6.9263(4) Å, b = 10.0832(7) Å, c = 17.3531(10) Å, α = 75.708(5)°, β = 87.142(5)°, γ = 74.935(6)°, V = 1133.92(13) Å 3 , Z = 2, Rgt(F) = 0.0605, wR ref (F 2 ) = 0.1661, T = 290(1) K.
values of the hydrogen atoms of methyl groups and oxygen were set to 1.5Ueq(C, O). All calculations were performed using the SHELXL-2014 program [2] .
Discussion
Compounds with arylpiperazine moieties have a wide range of bioactivities including antiarrhythmic [3] , diuretic [4] , antiallergic [5] , antidepressant [6] , anxiolytic [7] , antipsychotic [8] , antimalarial [9] , antiplasmodial [10] and antiproliferative [11] properties. In addition, these compounds also display receptor-blocking properties [12] . Moreover, arylpiperazine derivatives have shown significant cytotoxic activity against the tested prostate cancer cells [13] . Although some crystal structures of arylpiperazine derivatives have been reported recently [14, 15] , the different functional groups and organic ligands would lead to various properties of molecules. Therefore, to further study and explore the new arylpiperazine derivatives, we report the crystal structure of the title compound. The molecule of the title compound presents the isoindoline-1,3-dione, piperazine ring, and two benzene ring groups. One nitrogen atom of piperazine connects the phenyl group via C-N bond, and the other N links the phenylethyl moiety. Then, the above phenylethyl is further connect to the isoindoline-1,3-dione group. The isoindoline-1,3-dione, and two aryl moieties are not in the same plane. The whole molecule displays the twisty conformation. In the molecule, the N(1)-C (7) , N(1)-C (8) 
